Financial Architects (New Jersey)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-200
Closed 1527
2019
Q1
$0 Hold
200
﹤0.01% 1565
2018
Q4
$0 Hold
200
﹤0.01% 1535
2018
Q3
$0 Hold
200
﹤0.01% 1538
2018
Q2
$1K Hold
200
﹤0.01% 1300
2018
Q1
$1K Hold
200
﹤0.01% 1365
2017
Q4
$1K Hold
200
﹤0.01% 1461
2017
Q3
$1K Hold
200
﹤0.01% 1462
2017
Q2
$1K Hold
200
﹤0.01% 1492
2017
Q1
$1K Sell
200
-84
-30% -$355 ﹤0.01% 1540
2016
Q4
$1K Sell
284
-259
-48% -$7.69K ﹤0.01% 1367
2016
Q3
$25K Hold
543
0.01% 791
2016
Q2
$28K Buy
543
+111
+26% +$5.51K 0.01% 700
2016
Q1
$18K Buy
+432
New +$22K 0.01% 613
2015
Q3
Sell
-800
Closed -$42K 982
2015
Q2
$42K Hold
800
0.02% 476
2015
Q1
$37K Buy
+800
New +$41.5K 0.01% 452

Other funds holding ISEE

Financial Architects (New Jersey)'s ISEE Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2019, closing a stake of 200 shares.

Financial Architects (New Jersey) first reported a position in ISEE in Q1 2015 and held it in 15 quarters. The position peaked at $42K in Q2 2015. 52 funds tracked by Wall St. Rank hold ISEE as of Q2 2019.

  • Financial Architects (New Jersey) reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 200 IVERIC bio, Inc. Common Stock shares in Q2 2019.
  • Financial Architects (New Jersey) first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 15 quarters.
  • Financial Architects (New Jersey)'s IVERIC bio, Inc. Common Stock position peaked at $42K in Q2 2015.
  • 52 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.